Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. (2022)
Attributed to:
Impact of an Enterobacteriaceae-rich microbial community on gut health
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fpubh.2022.766023
PubMed Identifier: 35223723
Publication URI: http://europepmc.org/abstract/MED/35223723
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in public health
ISSN: 2296-2565